{"version":"1.0","provider_name":"NephCure","provider_url":"https:\/\/nephcure.org\/es","author_name":"2120 Creative Development","author_url":"https:\/\/nephcure.org\/es\/author\/dev2120creative-com\/","title":"Atacicept for IgAN Washington, DC","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"SHBFSMb1Db\"><a href=\"https:\/\/nephcure.org\/es\/trials\/atacicept-for-igan-washington\/\">Atacicept para NIgA Washington, DC<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/nephcure.org\/es\/trials\/atacicept-for-igan-washington\/embed\/#?secret=SHBFSMb1Db\" width=\"600\" height=\"338\" title=\"&#8220;Atacicept for IgAN Washington, DC&#8221; &#8212; NephCure\" data-secret=\"SHBFSMb1Db\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/nephcure.org\/wp-includes\/js\/wp-embed.min.js\n<\/script>","description":"This study will evaluate the safety, tolerability, dose response and efficacy of atacicept in patients with IgA nephropathy and persistent proteinuria. The study hypothesis is that treatment with atacicept will reduce proteinuria compared to placebo. - Read more about Atacicept for IgAN Washington, DC on NephCure.","thumbnail_url":"https:\/\/nephcure.org\/wp-content\/uploads\/2024\/05\/Site-Image.jpg","thumbnail_width":1200,"thumbnail_height":675}